cT1-4 N0M0期头颈部基底样癌的选择性颈清扫术
基于2006至2017年美国国家癌症数据库的回顾性队列研究,纳入857例手术切除的cT1-4 N0M0期头颈部基底样癌患者,其中389例(45.4%)接受选择性颈清扫术(END)。END与总生存改善无关,但隐匿性淋巴结转移率达29.6%,作者认为这支持将END纳入头颈部基底样癌的手术治疗。
要点
- 857例患者中389例(45.4%)接受END,115例(29.6%)END检出隐匿性淋巴结转移。
- 接受颈部观察与END患者的5年总生存率分别为65.6%与66.8%(P=.652),无显著差异。
- END(HR 0.96,95%CI 0.71-1.28,P=.770)与隐匿性淋巴结转移(HR 1.12,95%CI 0.78-1.61,P=.551)均与总生存无关。
核心结论
- 近半数头颈部基底样癌患者接受了END,但END与总生存改善无关,即使按人口学、临床病理特征和辅助治疗分层后亦然。
- 然而隐匿性淋巴结转移率接近30%,作者认为这支持将END纳入头颈部基底样癌的手术治疗。
研究设计与样本
- 回顾性队列研究,使用2006至2017年医院为基础的美国国家癌症数据库。
- 纳入857例手术切除的cT1-4 N0M0期头颈部基底样癌患者。
- 采用线性、二元logistic、Kaplan-Meier和Cox比例风险回归模型进行分析。
主要发现
- 857例患者中男性占77.0%、白人占88.1%,肿瘤位于口腔者占21.5%、口咽者占42.9%,高级别者占76.9%,cT1-2期者占72.9%。
- 389例(45.4%)患者接受了END。
- 2006至2017年间,cT1-2期患者的END使用率从33.3%升至56.9%(R²=.699),cT3-4期患者则从66.7%变为57.9%(R²=.062),基本保持稳定。
- 115例(29.6%)END检出隐匿性淋巴结转移。
- 接受颈部观察与END患者的5年总生存率分别为65.6%与66.8%(P=.652)。
临床怎么用
- 作者认为,尽管END与总生存改善无关,但接近30%的隐匿性淋巴结转移率支持将END纳入头颈部基底样癌的手术治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the survival benefit of elective neck dissection (END) over neck observation in surgically resected cT1-4 N0M0 head and neck basaloid carcinoma (HNBC). STUDY DESIGN: Retrospective cohort study. SETTING: The 2006 to 2017 hospital-based National Cancer Database. METHODS: Patients with surgically resected cT1-4 N0M0 HNBC were selected. Linear, binary logistic, Kaplan-Meier, and Cox proportional hazards regression models were implemented. RESULTS: Of 857 patients satisfying inclusion criteria, the majority were male (77.0%) and white (88.1%) with disease of the oral cavity (21.5%) or oropharynx (42.9%) classified as high grade (76.9%) and cT1-2 (72.9%). 389 (45.4%) patients underwent END. END utilization between 2006 and 2017 increased for cT1-2 disease (33.3% vs 56.9%, R2 = .699) but remained relatively constant for cT3-4 disease (66.7% vs 57.9%, R2 = .062). One-hundred and fifteen (29.6%) ENDs detected occult nodal metastases (ONMs). The 5-year overall survival (OS) of patients undergoing neck observation and END was 65.6% and 66.8%, respectively (P = .652). END was not associated with improved OS in survival analyses stratified by patient demographics, clinicopathologic features, and adjuvant therapy. Compared with surgery alone, adjuvant radiotherapy (adjusted hazard ratio: 0.74, 95% confidence interval [CI]: 0.57-0.97, P = .031) was associated with improved OS. END (hazard ratio [HR]: 0.96, 95% CI: 0.71-1.28, P = .770) and ONM (HR: 1.12, 95% CI: 0.78-1.61, P = .551) were not associated with OS. CONCLUSION: END is performed in nearly half of patients with HNBC but is not associated with improved OS, even after stratifying survival analyses by patient demographics, clinicopathologic features, and adjuvant therapy. The rate of ONM approaching 30%, however, justifies inclusion of END in the surgical management of HNBC.
引用
- Patel AM, Haleem A, Choudhry HS, et al. Elective Neck Dissection in cT1-4 N0M0 Head and Neck Basaloid Carcinoma. Otolaryngol Head Neck Surg. 2024. PMID: 38613196. doi:10.1002/ohn.757
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。